These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Tramadol 37.5-mg/acetaminophen 325-mg combination tablets added to regular therapy for rheumatoid arthritis pain: a 1-week, randomized, double-blind, placebo-controlled trial. Lee EY, Lee EB, Park BJ, Lee CK, Yoo B, Lim MK, Shim SC, Sheen DH, Seo YI, Kim HA, Baek HJ, Song YW. Clin Ther; 2006 Dec; 28(12):2052-60. PubMed ID: 17296461 [Abstract] [Full Text] [Related]
14. Pharmacokinetic and pharmacodynamic properties of tramadol IR and SR in elderly patients: a prospective, age-group-controlled study. Likar R, Wittels M, Molnar M, Kager I, Ziervogel G, Sittl R. Clin Ther; 2006 Dec; 28(12):2022-39. PubMed ID: 17296459 [Abstract] [Full Text] [Related]
18. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study. Landau CJ, Carr WD, Razzetti AJ, Sessler NE, Munera C, Ripa SR. Clin Ther; 2007 Oct; 29(10):2179-93. PubMed ID: 18042474 [Abstract] [Full Text] [Related]
19. Oxymorphone extended-release tablets relieve moderate to severe pain and improve physical function in osteoarthritis: results of a randomized, double-blind, placebo- and active-controlled phase III trial. Matsumoto AK, Babul N, Ahdieh H. Pain Med; 2005 Oct; 6(5):357-66. PubMed ID: 16266356 [Abstract] [Full Text] [Related]
20. Efficacy and tolerability of paracetamol/tramadol (325 mg/37.5 mg) combination treatment compared with tramadol (50 mg) monotherapy in patients with subacute low back pain: a multicenter, randomized, double-blind, parallel-group, 10-day treatment study. Perrot S, Krause D, Crozes P, Naïm C, GRTF-ZAL-1 Study Group. Clin Ther; 2006 Oct; 28(10):1592-606. PubMed ID: 17157115 [Abstract] [Full Text] [Related] Page: [Next] [New Search]